CureMetrix, Inc.

CureMetrix is a San Diego-based medical software company specializing in AI-powered image analysis solutions for radiology, with a focus on breast cancer detection and women's health. The company develops clinical decision support software that integrates with mammography workflows to assist radiologists in early detection, risk stratification, and patient management. Product portfolio includes: cmAngio® for coronary artery calcification and cardiovascular risk assessment; cmAssist® for lesion detection and characterization support in mammography; cmTriage® for AI-prioritized worklist management to optimize radiologist workflow efficiency; and cmDensity™ for improved evaluation of dense breast tissue. All products employ proprietary algorithms designed to reduce false positives, support earlier detection of cancerous lesions, track treatment response over time, and improve clinical efficiency in imaging centers and hospital systems. CureMetrix markets its solutions globally and has received recognition including Fast Company finalist status and AuntMinnie.com Best of Radiology award. The company has partnered with major healthcare technology providers, including participation in the Philips Global Healthcare Innovation Challenge. Products are designed to integrate seamlessly into existing radiology information systems (RIS) and picture archiving and communication systems (PACS) workflows. The company emphasizes clinical validation through peer-reviewed publications and focuses on reducing healthcare costs while improving patient outcomes through technology-enabled diagnostic accuracy.